Michelle Le Selected Research

Michelle Le Research Topics

Disease

6	Chronic Urticaria 04/2024 - 06/2020
3	COVID-19 04/2024 - 01/2023
3	Atopic Dermatitis (Atopic Eczema) 01/2022 - 01/2021
2	Carcinogenesis 12/2022 - 10/2022
2	Dermatitis 01/2022 - 05/2021
2	Chronic Inducible Urticaria 01/2022 - 10/2021
2	Clostridium Infections 11/2021 - 06/2019
2	Carcinoma (Carcinomatosis) 01/2021 - 01/2017
1	Pneumonia (Pneumonitis) 04/2024
1	Asthma and Nasal Polyps 04/2024
1	Contracture 02/2024
1	Cicatrix (Scar) 02/2024
1	Wounds and Injuries (Trauma) 02/2024
1	Telangiectasis (Telangiectasia) 02/2024
1	Colorectal Neoplasms (Colorectal Cancer) 01/2024
1	Substance-Related Disorders (Drug Abuse) 11/2023
1	Major Depressive Disorder (Major Depressive Disorders) 11/2023
1	Schizophrenia (Dementia Praecox) 11/2023
1	Injection Site Reaction 10/2023
1	Angioedema 10/2023
1	Exanthema (Rash) 10/2023
1	Hypersensitivity (Allergy) 10/2023
1	Infections 10/2023
1	Mastocytosis 10/2023
1	Urticaria (Hives) 10/2023
1	Melanoma (Melanoma, Malignant) 01/2023
1	Systemic Scleroderma (Systemic Sclerosis) 12/2022
1	Dermatomyositis (Dermatopolymyositis) 12/2022
1	Cutaneous Lupus Erythematosus 12/2022
1	Neoplasm Metastasis (Metastasis) 10/2022
1	Cold Urticaria 01/2022
1	Inflammation (Inflammations) 01/2022
1	Neurodermatitis (Lichen Simplex Chronicus) 01/2022
1	Bullous Pemphigoid (Pemphigoid) 01/2022
1	Eosinophilia 01/2022
1	Disease Susceptibility (Diathesis) 01/2022
1	Skin Diseases (Skin Disease) 01/2022
1	Skin Neoplasms (Skin Cancer) 01/2022
1	Anaphylaxis (Anaphylactic Shock) 01/2022
1	Conjunctivitis 05/2021
1	Pruritus (Itching) 05/2021
1	Eczema 05/2021
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 07/2020
1	Pemphigus (Pemphigus Vulgaris) 09/2019
1	Critical Illness (Critically Ill) 06/2019
1	Food Hypersensitivity (Food Allergy) 01/2019
1	Plasmacytoma 01/2018
1	Multiple Myeloma 01/2018
1	Cutaneous Mastocytosis 11/2017
1	Disease Progression 11/2017
1	Systemic Mastocytosis 11/2017

Drug/Important Bio-Agent (IBA)

4	Omalizumab (Xolair)FDA Link 04/2024 - 11/2017
3	Monoclonal AntibodiesIBA 04/2024 - 05/2021
3	Histamine Antagonists (Antihistamines)IBA 01/2022 - 11/2017
2	Immunoglobulin E (IgE)IBA 04/2024 - 01/2022
2	Messenger RNA (mRNA)IBA 10/2023 - 01/2023
2	dupilumabIBA 01/2022 - 05/2021
2	Epinephrine (Adrenaline)FDA LinkGeneric 01/2022 - 01/2019
2	Non-Sedating Histamine H1 Antagonists (Histamine H1 Antagonists, Non Sedating)IBA 11/2020 - 06/2020
2	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2019 - 11/2017
1	Antiviral Agents (Antivirals)IBA 04/2024
1	Dopamine (Intropin)FDA LinkGeneric 11/2023
1	COVID-19 VaccinesIBA 10/2023
1	VaccinesIBA 10/2023
1	InterferonsIBA 12/2022
1	RNA (Ribonucleic Acid)IBA 12/2022
1	CollagenIBA 12/2022
1	Long Noncoding RNAIBA 12/2022
1	Matrix Metalloproteinases (MMPs)IBA 10/2022
1	Metalloproteases (Metalloproteinases)IBA 10/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	CytokinesIBA 01/2022
1	Immunoglobulin A (IgA)IBA 05/2021
1	Interleukin-13IBA 05/2021
1	lebrikizumabIBA 05/2021
1	InterleukinsIBA 05/2021
1	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 01/2021
1	Janus Kinase InhibitorsIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2020
1	Fluorine-18IBA 01/2018
1	Imatinib Mesylate (Gleevec)FDA Link 11/2017
1	TritiumIBA 01/2017

Therapy/Procedure

4	Therapeutics 04/2024 - 11/2017
2	Mohs Surgery (Mohs' Micrographic Surgery) 02/2024 - 01/2023
2	Fecal Microbiota Transplantation 11/2021 - 06/2019
2	Biological Therapy 05/2021 - 01/2021
1	Artificial Respiration (Mechanical Ventilation) 04/2024
1	Lasers (Laser) 02/2024
1	Traction 01/2024
1	Surgical Amputation (Amputations) 01/2023
1	Secondary Prevention 01/2021
1	Colectomy 06/2019
1	Drug Therapy (Chemotherapy) 11/2017